UBS AG - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 38 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q3 2014$9,000
-25.0%
15,620
+78.4%
0.00%
Q2 2014$12,000
-60.0%
8,755
-46.1%
0.00%
Q1 2014$30,000
-57.1%
16,255
-63.6%
0.00%
Q4 2013$70,000
-42.1%
44,705
-9.6%
0.00%
Q3 2013$121,000
+112.3%
49,478
+150.3%
0.00%
Q2 2013$57,00019,7650.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q4 2013
NameSharesValueWeighting ↓
NEXT Financial Group, Inc 43,000$19,0000.01%
VSR Financial Services, Inc. 119,630$54,0000.01%
TCI Wealth Advisors, Inc. 1,200$1,0000.00%
BANK OF AMERICA CORP /DE/ 11,944$5,0000.00%
STIFEL FINANCIAL CORP 24,500$11,0000.00%
FIRST MANHATTAN CO. LLC. 1,000$00.00%
WELLS FARGO & COMPANY/MN 1,000$00.00%
GROUP ONE TRADING, L.P. 38,529$18,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 44,017$20,0000.00%
HOWE & RUSLING INC 1,017$00.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders